CytomX Therapeutics CTMX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's interest income?
- CytomX Therapeutics (CTMX) reported interest income of $1.49M in Q1 2026.
- How has CytomX Therapeutics's interest income changed year-over-year?
- CytomX Therapeutics's interest income increased by 56.0% year-over-year, from $955K to $1.49M.
- What is the long-term trend for CytomX Therapeutics's interest income?
- Over 4 years (2021 to 2025), CytomX Therapeutics's interest income has grown at a 112.6% compound annual growth rate (CAGR), from $255K to $5.21M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.